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Background: Gastrointestinal stromal tumours are the most common mesenchymal malignancies of the
gastrointestinal (GI) tract and gastric leiomyosarcoma represent 1-3% of gastric malignancies.
Case presentation: We report a case of a 69-year- old black African man who presented with a rare cause of
gastric outlet obstruction and duodenal perforation. A Billroth- II gastrectomy was performed and histology
confirmed a gastric leiomyosarcoma.
Conclusions: It is important to identify the gastric leiomyosarcoma which is a variant of the more common
malignant gastrointestinal stromal tumours as the pathogenesis and management are currently well established.
As the facilities for differentiating these are not easily available in resource-limited areas gastrointestinal stromal
tumours may remain underdiagnosed and undertreated.
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Gastrointestinal stromal tumours (GISTs) are the most
common mesenchymal (non-epithelial) malignancies of
the gastrointestinal (GI) tract [1,2]. Most arise in the
stomach (leiomyosarcoma) representing 0.1-3% of gas-
tric malignancies, or small intestine, and less frequently
in the oesophagus, mesentery, omentum, colon or rec-
tum [1]. Historically, GISTs were considered to be of
smooth muscle origin and were generally regarded as
benign (leiomyomas) or malignant (leiomyosarcomas).
However, only a minority of stromal tumours have the
typical features of smooth muscle with some having a
more neural appearance and others appearing undiffer-
entiated [3]. The discovery of CD34 expression (80-90%)
and the receptor tyrosine kinase KIT (CD117) in many
GISTs suggested that they were a specific entity distinct
from smooth muscle tumours [4]. This has led to the
widely accepted classification of mesenchymal tumours
of the GI tract into GISTS, true smooth muscle tu-
mours, and, far less frequently, true schwann cell tu-
mours [3]. Appropriate management of gastrointestinal
mesenchymal tumours requires accurate diagnosis and* Correspondence: elroypat@yahoo.co.uk
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prognosis of leiomyosarcoma is poor, death often result-
ing from local spread and/or metastases.
Case presentation
A 69-yr- old African man was admitted as an emergency
with a 2- week history of symptoms of gastric outlet ob-
struction. He had postpandrial vomiting associated with
upper abdominal bloatedness and complained of a con-
stant epigastric pain in the past 48 hrs. He had no haeme-
temesis nor melaena. There was no antecedent history of
peptic ulcer disease nor a past history of similar symp-
toms. He had anorexia, weight loss and constipation. On
physical examination he appeared pale and dehydrated.
BP was 100/80 mmHg, HR 96/min, temperature 36.5°C.
The distension of the upper abdomen was consistent with
a dilated stomach. He had no definite signs of peritonism
(rebound tenderness, guarding, abdominal rigidity) but
mild tenderness on deep palpation of an epigastric mass.
The differential diagnosis included a malignant gastric
outlet obstruction or an acquired pyloric stenosis from
chronic peptic ulcer disease. The haemoglobin level was
10 gm/l, a white cell count was not available but the urea
and electrolytes were within normal limits. An erect chest
x-ray showed no air under the diaphragm. A plain abdom-
inal x-ray revealed a grossly dilated stomach with foodLtd. This is an Open Access article distributed under the terms of the Creative
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Figure 1 Large gastric leiomyosarcoma (>8 cm) - high chance
of dissemination.
Figure 2 Photomicrograph showing the spindle cells of
leiomyosarcoma with multiple abnormal mitosis. (haematoxylin
and eoisin stain).
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tumour. Following resuscitation for 48 hrs with i/v fluids,
antibiotics and nasogastric suction, he consented to a
laparotomy. At laparotomy there was pus emanating from
the left subhepatic space. The stomach was grossly dilated
with a 3-4 cm anterior perforation of the 1st part of the
duodenum with surrounding necrosis overlying the
common bile duct and gastroduodenal artery. There
was seeding of tumour deposits into the serosa and ad-
jacent omentum. The liver appeared normal on palpa-
tion. Kocherization of the duodenum allowed a difficult
Billroth II partial gastrectomy and a retrocolic gastroje-
junostomy fashioned. An open right subhepatic drain
was inserted. Intraoperatively he was haemodynamically
unstable with hypotension requiring a transfusion of 2
units of blood. Postoperatively, he remained haemo-
dynamically unstable (BP 93/73 mmHg, pulse 97/min,)
with associated sweating and oliguria. He was apyrexial
but hypoglycaemic with a fasting blood sugar (FBS) of
10.6 g/dl (n 14-18 g/dl). He responded to fluid resuscita-
tion and glucose repletion. He tolerated liquid diet on
the 5th post operative day and his haemoglobin level was
12.6 g/l. On the 7th postoperative day he suddenly became
clammy and died. A postmortem was not done. The hist-
ology reported a partial gastrectomy specimen measuring
10.0 x 8.0 x 7.0 cm, rough surfaced, in folds, brownish-
yellow colouration and elastic in consistency. Microscopy
showed a proliferation of fusiform cells with large, central
hyperchromatic nuclei, mottled chromatin and abundant
mitosis showing smooth muscle differentiation invading a
myxoid and fibro-fatty stroma. This was consistent with
a malignant gastrointestinal stroma tumour (malignant
GIST) of the leiomyosarcoma type (Figures 1 and 2).
Discussion
Although almost all perforated gastric ulcers can be effect-
ively managed by laparotomy and omental patch repair,
intraoperative biopsy and follow-up endoscopy with re-
peat biopsy is essential to avoid an underlying malignancy.
Large perforation of gastric ulcers usually require distal
gastrectomies as in this case [5]. The histology of the
resected specimen revealed a malignant GIST (leiomyo-
sarcoma). Gastric leiomyosarcomas represent 10–15% of
mesenchymal tumours and the age distribution and clin-
ical presentation are similar to malignant gastrointestinal
stromal tumours (GISTs). The associated systemic symp-
toms such as fever, night sweats and weight loss are very
rare in other sarcomas [1]. The median age at diagnosis is
50-60 years with a slight male predominance. They are
often clinically silent until they reach a large size, bleed or
rupture [6,7]. Thus, the diagnosis is rarely made preopera-
tively. Since in many cases the mucosa is normal, a defini-
tive diagnosis for resectable tumour is often made after
surgery [7-9]. Seeding of tumour deposits into the serosaor omentum is almost invariably a sign of malignancy. In
this case, the large tumour size greater than 8 cm and mu-
cosal perforation indicated rapid tumour growth and more
likely to be associated with disseminated disease [1,3]. The
optimisation of this patient’s fitness for surgery was com-
promised by the emergency presentation with gastric outlet
obstruction and localized peritonitis. This was exacerbated
by the lack of adequate and appropriate postoperative care
usually rendered in a high dependency or intensive care
unit especially in this patient requiring cardiac and renal
support. These are the short-comings of performing major
surgery in poor resourced areas. It is known that cancer
deaths in hospital involves patient factors, tumour factors
and surgeon-related factors [10]. Both tumour (large size
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not favourable. The probable immediate cause of death was
cardiac failure as he remained cardiovascularly unstable
perioperatively.
In resourced areas, initial diagnosis of malignant GIST is
based on imaging. Endoscopic ultrasonography (EUS) espe-
cially of the oesophagus, stomach, duodenum and anorec-
tum can confirm the diagnosis of small lesions less than
2 cm. For large tumours, computed tomography (CT) of
chest, abdomen and pelvis would assess primary tumour
extension and stage for metastases. Percutaneous (US or
CT -guided) or laparoscopically- guided biopsies are not
used in resectable disease due to the risk of tumour rupture
or seeding unless it may result in a change of treatment [8].
Laparoscopy may be considered to stage for peritoneal and
distant spread of disease [7,9]. For patients with unresect-
able and/or metastatic tumours, an endoscopic or percu-
taneous biopsy is taken for a definitive diagnosis before
treatment.
As the morphological spectrum of GISTs is wider than
previously recognized, macroscopic examination of the
site of the resected tumour, with an adequate sampling for
histological examination and for immunohistochemistry
should be performed [9]. In this case, the histopathological
diagnosis of a malignant GIST would have been supported
by a positive expression of CD34 or CD117 [4,11]. Evalu-
ation of respectability of gastrointestinal stromal tumour
is determined by the surgeon and depends on the stage
and the individual patient’s fitness for surgery [7,8]. As they
rarely metastasise to lymph nodes, extended lymphade-
nectomy is seldom warranted. En bloc resection of
involved adjacent organs is necessary for oncological clear-
ance [8,9]. As metastasis is primarily haematogenous, the
five year survival following surgical (RO) resection is 37-
54% [5]. Neither palliative or adjuvant radiotherapy nor
standard chemotherapy has been shown to be of benefit
[7,8]. The early results suggest that molecular therapy with
the tyrosine kinase inhibitor, imitanib mesylate, may play
an important role as adjuvant therapy following GIST re-
section. It increases recurrence –free survival as shown by
contrast enhanced CT scanning [12,13].
Conclusion
It is important to identify the gastric leiomyosarcoma which
is a variant of the more common malignant gastrointestinal
stromal tumour (GISTs) whose pathogenesis and manage-
ment are currently well established. As the facilities for dif-
ferentiating these are not easily available gastrointestinal
stromal tumours may remain underdiagnosed and under-
treated in resource-limited areas.
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